Lesion Dosimetry for [


Journal

Journal of nuclear medicine : official publication, Society of Nuclear Medicine
ISSN: 1535-5667
Titre abrégé: J Nucl Med
Pays: United States
ID NLM: 0217410

Informations de publication

Date de publication:
11 2023
Historique:
received: 21 03 2023
revised: 11 07 2023
pmc-release: 01 05 2024
medline: 6 11 2023
pubmed: 1 9 2023
entrez: 31 8 2023
Statut: ppublish

Résumé

A single-institution prospective pilot clinical trial was performed to demonstrate the feasibility of combining [

Identifiants

pubmed: 37652541
pii: jnumed.123.265763
doi: 10.2967/jnumed.123.265763
pmc: PMC10626375
doi:

Substances chimiques

PSMA-617 0
Radiopharmaceuticals 0
Dipeptides 0
Prostate-Specific Antigen EC 3.4.21.77
Heterocyclic Compounds, 1-Ring 0
Lutetium 5H0DOZ21UJ

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1779-1787

Informations de copyright

© 2023 by the Society of Nuclear Medicine and Molecular Imaging.

Références

Eur Urol. 2016 Jan;69(1):9-12
pubmed: 26189689
EJNMMI Phys. 2022 Dec 13;9(1):86
pubmed: 36512147
J Nucl Med. 2019 Apr;60(4):517-523
pubmed: 30291192
J Clin Oncol. 1995 Jan;13(1):8-10
pubmed: 7799047
Med Phys. 2017 Jun;44(6):e1-e42
pubmed: 28120467
J Nucl Med. 2019 Jun;60(6):786-793
pubmed: 30530831
J Nucl Med. 2022 Jul;63(7):1027-1032
pubmed: 34772795
J Nucl Med. 2017 Mar;58(3):445-450
pubmed: 27660138
J Clin Oncol. 2022 Oct 10;40(29):3377-3382
pubmed: 36001857
J Nucl Med. 2022 Nov;63(11):1665-1672
pubmed: 35422445
Mol Imaging Biol. 2015 Aug;17(4):575-84
pubmed: 26013479
J Nucl Med. 2005 Jan;46 Suppl 1:99S-106S
pubmed: 15653658
Phys Med Biol. 2018 Dec 19;64(1):01TR01
pubmed: 30523903
Adv Radiat Oncol. 2021 Dec 05;7(2):100864
pubmed: 35036636
Radiat Oncol. 2022 Mar 18;17(1):54
pubmed: 35303922
Int J Radiat Oncol Biol Phys. 2004 May 1;59(1):228-41
pubmed: 15093920
Am J Clin Oncol. 2017 Aug;40(4):418-422
pubmed: 25647831
Eur J Nucl Med Mol Imaging. 2018 Dec;45(13):2456-2474
pubmed: 30218316
BMC Cancer. 2023 Mar 23;23(1):268
pubmed: 36959540
Mol Imaging Biol. 2022 Jun;24(3):444-452
pubmed: 34724140
Clin Cancer Res. 2021 Jul 1;27(13):3595-3601
pubmed: 33883176
J Nucl Med. 2008 Nov;49(11):1884-99
pubmed: 18927342
Med Phys. 2008 Mar;35(3):1123-34
pubmed: 18404947
Eur Urol Oncol. 2018 Dec;1(6):531-537
pubmed: 31158100
N Engl J Med. 2021 Sep 16;385(12):1091-1103
pubmed: 34161051
J Nucl Med. 2022 Dec 08;64(5):782-790
pubmed: 37074039
Int J Radiat Oncol Biol Phys. 2011 Jul 15;80(4):1256-62
pubmed: 20950958
EJNMMI Phys. 2020 Feb 11;7(1):9
pubmed: 32048097
Int J Radiat Oncol Biol Phys. 2021 Jul 1;110(3):672-679
pubmed: 33422612
J Nucl Med. 2021 Dec;62(Suppl 3):12S-22S
pubmed: 34857617
Eur J Nucl Med Mol Imaging. 2022 Jan;49(2):460-469
pubmed: 34218300
Eur J Nucl Med Mol Imaging. 2023 May;50(6):1811-1821
pubmed: 36702927
JAMA Oncol. 2019 Jun 01;5(6):856-863
pubmed: 30920593
Nat Rev Urol. 2017 Jan;14(1):15-25
pubmed: 27725639
Semin Radiat Oncol. 2008 Oct;18(4):234-9
pubmed: 18725109
Cancers (Basel). 2021 Oct 04;13(19):
pubmed: 34638466
Phys Med Biol. 2019 Jul 18;64(14):145017
pubmed: 31207583
CA Cancer J Clin. 2023 Jan;73(1):17-48
pubmed: 36633525
Semin Nucl Med. 2022 Mar;52(2):243-254
pubmed: 34893320
Med Phys. 2017 Dec;44(12):6280-6288
pubmed: 28921613
Cancer Imaging. 2022 Jul 22;22(1):36
pubmed: 35869521
Urology. 2022 Dec;170:146-153
pubmed: 36115426
Nucl Med Biol. 2021 Jul-Aug;98-99:40-58
pubmed: 34029984
J Nucl Med. 2009 Mar;50(3):477-84
pubmed: 19258258
Asia Ocean J Nucl Med Biol. 2023;11(1):44-54
pubmed: 36619190
Eur Urol. 2018 Apr;73(4):485-487
pubmed: 29132714
J Nucl Med. 2019 Jan;60(1):50-59
pubmed: 29976698
Lancet Oncol. 2017 Jul;18(7):e414-e423
pubmed: 28677577
Cancer Biother Radiopharm. 2007 Feb;22(1):1-23
pubmed: 17627411
BJU Int. 2023 Jul;132(1):65-74
pubmed: 36797449
J Clin Invest. 2019 Feb 1;129(2):786-801
pubmed: 30480549

Auteurs

Milan Grkovski (M)

Department of Medical Physics, Memorial Sloan Kettering Cancer Center, New York, New York; grkovskm@mkscc.org bodeil@mkscc.org.

Joseph A O'Donoghue (JA)

Department of Medical Physics, Memorial Sloan Kettering Cancer Center, New York, New York.

Brandon S Imber (BS)

Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, New York.

George Andl (G)

Varian Medical Systems Inc., Palo Alto, California; and.

Cheng Tu (C)

Varian Medical Systems Inc., Palo Alto, California; and.

Daniel Lafontaine (D)

Department of Medical Physics, Memorial Sloan Kettering Cancer Center, New York, New York.

Jazmin Schwartz (J)

Department of Medical Physics, Memorial Sloan Kettering Cancer Center, New York, New York.

Maria Thor (M)

Department of Medical Physics, Memorial Sloan Kettering Cancer Center, New York, New York.

Michael J Zelefsky (MJ)

Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, New York.

John L Humm (JL)

Department of Medical Physics, Memorial Sloan Kettering Cancer Center, New York, New York.

Lisa Bodei (L)

Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York grkovskm@mkscc.org bodeil@mkscc.org.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH